Partner/Owner

Representative before the EPO

Employment test 51 - 200 employees
Company dna maiwald patentanwalts gmbh
operating since 1995
Headquarter in Munich and 4 offices
active in Legal Services and IP Consulting

We have observed 37 EP applications Dirk Bühler has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after April 22, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12715356

BIOMARKERS FOR PAIN INTENSITY

IPC classification:
G01N 33/68, A61K 39/395
Applicant:
Graz University of Medicine (Medizinische Universität Graz)
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12724940

MAGEA3 BINDING ANTIBODIES

IPC classification:
C07K 16/30
Applicant:
University of Zurich (Universität Zürich)
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12723192

MAGEA3 BINDING ANTIBODIES

IPC classification:
C07K 16/30
Applicant:
University of Zurich (Universität Zürich)
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12829385

METHODS FOR DETERMINING RESPONSIVENESS TO A DIHYDROFOLATE REDUCTASE INHIBITOR

IPC classification:
A61P 35/00, C07H 21/00, C12Q 1/68, C40B 30/06
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11838922

A2A ANTAGONISTS AS COGNITION AND MOTOR FUNCTION ENHANCERS

IPC classification:
A61K 9/00, A61K 31/198, A61K 31/44
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Agent:
Hugh Goodfellow, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13158164

Method of generating a medical suggestion as a support in medical decision making

IPC classification:
G06F 19/00
Applicant:
Medesso GmbH
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP12795978

ANTI-CD98 ANTIBODIES AND METHODS OF USE THEREOF

IPC classification:
A61P 35/00, C07K 16/28
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Agent:
Jones Day
Status:
EXAMINATION IN PROGRESS
EP12806868

METHODS FOR TREATING ACNE

IPC classification:
A61P 17/10, C07K 16/24, A61K 39/395
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
The patent has been granted
EP13701317

HUMANIZED ANTIBODIES WITH ULTRALONG CDR3S

IPC classification:
C07K 14/54, C07K 16/00, C07K 16/10, C07K 16/46, C07K 19/00
Applicant:
The Scripps Research Institute
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP12852317

BINDING MOLECULES SPECIFIC FOR HER3 AND USES THEREOF

IPC classification:
C07K 16/40
Applicant:
MedImmune, LLC
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP14166974

Methods and compositions for generation of germline human antibody genes

IPC classification:
C07H 21/04, C07K 16/00, C12N 9/00, C12N 9/50, C12N 15/13, C12P 19/34, C12Q 1/68
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13718839

HIGH COMPLEXITY siRNA POOLS

IPC classification:
C12N 15/113, A61K 31/713
Applicant:
University of Regensburg (Universität Regensburg)
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP14188580

Methods for the treatment of gout

IPC classification:
C07K 16/24, A61K 39/00, A61K 39/395, A61K 45/06
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP13798617

CD44V6-DERIVED PEPTIDES FOR TREATING METASTASIZING CANCERS

IPC classification:
A61P 35/00, A61K 38/17
Applicant:
Karlsruher Institut für Technologie
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP14191630

Controlled release hydrocodone formulations

IPC classification:
A61K 9/22, A61K 9/24, A61K 31/485
Applicant:
Euro-Celtique S.A.
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP11801672

CANCER GENE THERAPY USING NUCLEIC ACIDS ENCODING US28 AND G-PROTEIN

IPC classification:
A61P 35/00, A61K 38/16, A61K 48/00
Applicant:
Graz University of Medicine (Medizinische Universität Graz)
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12701463

COMBINATION THERAPY INCLUDING TUMOR ASSOCIATED ANTIGEN BINDING ANTIBODIES

IPC classification:
C07K 16/28, C07K 16/30, A61K 39/00, A61K 39/395
Applicant:
University of Zurich (Universität Zürich)
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
PATENT GRANTED
EP14770104

COMPOSITION AND METHODS BASED ON NEUTRALIZING ANTIBODIES DELIVERED INTRANASALLY FOR ENHANCED THERAPEUTIC EFFICACY

IPC classification:
A61K 39/42
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Agent:
Elisabetta Maria Ester Mauri, PGA S.r.l.
Status:
GRANT OF PATENT INTENDED
EP16158254

METHODS FOR TREATING ACNE

IPC classification:
A61P 17/10, C07K 16/24, A61K 39/395
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP10745125

PRODUCTION PROCESS FOR AMINO ACIDS OF THE ASPARTATE FAMILY USING MICROORGANISMS

IPC classification:
C12N 15/62, C12N 15/77, C12P 13/08, C12P 13/20, C12R 1/15
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
PATENT GRANTED
EP14798848

HYDROMORPHONE AND NALOXONE FOR TREATMENT OF PAIN AND OPIOID BOWEL DYSFUNCTION SYNDROME

IPC classification:
A61P 1/00, A61P 29/00, A61K 31/485, A61K 45/06
Applicant:
Euro-Celtique S.A.
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP10857022

PHARMACEUTICAL COMPOSITION FOR TREATING ANXIETY DISORDER, CONTAINING N-ACETYL-L-CYSTEINE OR DERIVATIVE THEREOF

IPC classification:
A61P 25/22, A61K 31/18, A61K 31/195, A61K 31/198, A61K 31/216, A61K 31/355, A61K 31/51, A61K 31/525, A61K 31/55, A61K 31/5513, A61K 31/702, A61K 33/00, A61K 38/05, A61K 38/17, A61K 38/18, A61K 38/21, A61K 45/06
Applicant:
Seoul National University Research & Development Business Foundation
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
PATENT GRANTED
EP16704085

GLYCAN THERAPEUTICS AND RELATED METHODS THEREOF

IPC classification:
A61K 45/06
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Agent:
Tobias Rutger Simpson, Mathys & Squire LLP
Status:
The patent has been granted
EP15700645

HERBICIDAL MIXTURE COMPRISING IMAZETHAPYR AND CYCLOXYDIM

IPC classification:
A01N 43/18, A01N 43/50, A01P 13/00
Applicant:
BASF Agrochemical Products B.V.
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP16181211

TISSUE DRESSING MATERIAL

IPC classification:
A61L 15/16, A61L 15/28, A61L 26/00
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Agent:
Stefan Rolf Huebner, SR Huebner & Kollegen
Status:
Request for examination was made
EP15769495

REDUCING DRUG LIKING IN A SUBJECT

IPC classification:
A61P 25/04, A61P 25/36, C07D 489/02, C07D 489/08, A61K 9/24, A61K 31/485
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP15721694

KV1.3 POTASSIUM CHANNEL ANTAGONISTS

IPC classification:
C07K 14/47
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP15733758

METHOD FOR OBTAINING GLOBALLY ACTIVATED MONOCYTES

IPC classification:
A61P 35/00, C12N 5/0784, A61K 35/15
Applicant:
Yale University
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP15839879

USES OF ANTI-HER3 ANTIBODIES FOR TREATING CANCER

IPC classification:
C07H 21/04, C07K 16/00, A61K 39/395
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP15849576

METHOD TO REDUCE ONCOGENIC POTENTIAL OF INDUCED PLURIPOTENT STEM CELLS FROM AGED DONORS

IPC classification:
C07K 14/47, C12N 5/0735, C12N 5/074, C12N 15/12, C12N 15/85
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP15784371

TOLEROGENIC DENDRITIC CELLS, METHODS OF PRODUCING THE SAME, AND USES THEREOF

IPC classification:
C12N 5/0784, A61K 35/12, A61K 35/15
Applicant:
Sotio as
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP15855359

METHODS AND COMPOSITIONS PARTICULARLY FOR TREATMENT OF ATTENTION DEFICIT DISORDER

IPC classification:
A61P 25/00, C07D 211/34, A61K 9/16, A61K 9/56, A61K 31/4458
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP15807649

CD44V6-DERIVED CYCLIC PEPTIDES FOR TREATING CANCERS AND ANGIOGENESIS RELATED DISEASES

IPC classification:
A61P 35/00, C07K 14/705, A61K 38/17
Applicant:
Heidelberg University (Ruprecht-Karls-Universität Heidelberg)
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP17175790

ANTIMICROBIAL COMPOSITION

IPC classification:
A61L 15/16, A61L 15/28, A61L 26/00
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Agent:
SR Huebner & Kollegen
Status:
The application has been published
EP16743841

OLIGOSACCHARIDE COMPOSITIONS FOR USE AS FOOD INGREDIENTS AND METHODS OF PRODUCING THEREOF

IPC classification:
A23L 2/60
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP16743843

OLIGOSACCHARIDE COMPOSITIONS FOR USE ANIMAL FEED AND METHODS OF PRODUCING THEREOF

IPC classification:
A23K 10/00
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP16743842

OLIGOSACCHARIDE COMPOSITIONS FOR USE IN NUTRITIONAL COMPOSITIONS, AND METHODS OF PRODUCING THEREOF

IPC classification:
C07H 3/06
Agent:
Dirk Bühler, Maiwald Patentanwalts GmbH
Status:
Request for examination was made

Please Sign in to use this feature